Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
03/2009
03/11/2009CN101381342A Piperazine derivatives and applications thereof
03/11/2009CN101381326A 2-cyano-3-(substituted) amidine-3-phenyl acrylates compounds, preparation method and use thereof
03/11/2009CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/11/2009CN100467440C Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
03/10/2009US7501527 Method for the production of fluoromethyl-substituted heterocycles
03/10/2009US7501421 Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands
03/10/2009CA2377233C Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
03/10/2009CA2342210C Thiazoline acid derivatives
03/05/2009WO2009027450A1 Novel bradykinin b1-antagonists
03/05/2009WO2009027077A2 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof
03/05/2009WO2009026701A1 Sirtuin inhibitors
03/05/2009WO2009010454A3 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
03/05/2009WO2008138591A3 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
03/05/2009WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors
03/05/2009US20090062549 Process for the preparation of pramipexole and new anhydrous forms of its dihydrochloride
03/05/2009US20090062541 Reacting an aryl or heteroaryl halide with a cyanide donor,potassium hexacyanoferrate(II) or (III), in the presence of a copper compound and a 1-alkyl imidazole as a catalyst stabilizer); nontoxic; industrial scale; cost efficiency; chemical intermediates for agrochemicals and pharmaceuticals
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
03/05/2009US20090062259 Bezothiazol Derivatives as Beta2 Adrenoreceptor Agonists
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/05/2009US20090060853 Aminophenylbenzothiazole compounds
03/05/2009CA2697946A1 New bradykinin b1-antagonists
03/04/2009EP2030974A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents
03/04/2009EP2030635A1 Composition for diagnosing amyloid-related disease
03/04/2009EP2029562A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors
03/04/2009EP2029561A1 Tricyclic compound and pharmaceutical use thereof
03/04/2009EP2029542A2 Primary amines as renin inhibitors
03/04/2009EP2029530A1 Ethenyl carboxamide derivatives useful as microbiocides
03/04/2009EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
03/04/2009CN101379559A Metal chelates and their use in optical recording media having high storage capacity
03/04/2009CN101379049A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
03/04/2009CN101379030A Sulfonamide derivatives to treat infection with hepatitis c virus
03/04/2009CN100465169C A preparation method of nitazoxanide
03/03/2009US7498445 4-Methyl-5-(-2-nitrooxy-ethyl)-2-(1-nitrooxy-ethyl)-thiazole for example; compound forms a naturally occurring metabolite when NO is released; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders
03/03/2009US7498436 Substituted hydroxyethylamines
03/03/2009US7497878 Azo dyes containing a sulphonamide or amide function for the dyeing of human keratin fibers and method of dyeing and dyeing compositions containing them
03/03/2009CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
02/2009
02/26/2009WO2009026408A1 Therapeutic quinoline and naphthalene derivatives
02/26/2009WO2009026227A2 Highly selective sigma receptor ligands
02/26/2009WO2009025358A1 Heterocyclic compound and use thereof
02/26/2009WO2009024287A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
02/26/2009WO2008130395A3 Desferrithiocin analogue actinide decorporation agents
02/26/2009US20090054655 Process for the Production of Organic Oxides
02/26/2009US20090054642 Novel benzamidine derivative, process for the preparation thereof and pharmaceutical composition comprising same
02/26/2009US20090054496 N-[o-(cyclopropylcyclobutyl)phenyl]heterocyclecarboxamides, for use in agriculture or horticulture for controlling or preventing infestations of plants by phytopathogenic microorganisms, especially fungi.
02/26/2009US20090054493 Thiazole derivatives as ppar delta ligands and their manufacturing process
02/26/2009US20090054479 Fused heterocyclic derivatives as ppar modulators
02/26/2009US20090054463 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
02/26/2009US20090054457 Substituted heterocyclic compounds
02/26/2009US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors
02/26/2009US20090054435 Phenoxyalkanoic Acid Compound
02/26/2009US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment
02/26/2009US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands
02/26/2009US20090053175 Substitute pyrrolidine derivatives
02/26/2009DE102007040243A1 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen 17beta-dehydrogenase type 1 Hydroxysteriod inhibitors for the treatment of hormone-dependent diseases
02/26/2009CA2697284A1 Therapeutic quinoline and naphthalene derivatives
02/26/2009CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
02/25/2009EP2028185A1 Tubulysin and tubulysin agent
02/25/2009EP1856031B1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
02/25/2009EP1521752B1 Macrocycles for the treatment of cancer
02/25/2009CN101374824A Heterocyclic GABA-B modulators
02/25/2009CN101374823A Organic compounds
02/25/2009CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
02/25/2009CN101374807A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
02/24/2009US7495106 O-aminophenol-containing AB-monomer for heterocyclic rigid-rod polymers
02/24/2009US7495021 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
02/24/2009CA2219455C Use of pyrrolidine derivatives for treating alcoholism
02/19/2009WO2009023758A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
02/19/2009WO2009023757A1 Therapeutic compounds
02/19/2009WO2009009378A3 Cathepsin-d neuroprotection
02/19/2009WO2008155615A3 An improved process for the preparation of cephalosporin antibiotic
02/19/2009US20090048310 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
02/19/2009US20090048298 Novel acetyl-CoA Carboxylase (ACC) Inhibitors and their use in Diabetes, Obesity and Metabolic Syndrome
02/19/2009US20090048258 Amide Compound
02/19/2009US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
02/19/2009US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors
02/19/2009US20090048226 Inhibitors of caspases
02/19/2009US20090048224 Compounds and methods of use
02/19/2009US20090048112 Novel Herbicides
02/19/2009US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation
02/19/2009CA2696404A1 Therapeutic compounds
02/19/2009CA2696315A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
02/19/2009CA2685605A1 Treatment of duchenne muscular dystrophy
02/18/2009EP2024349A2 Novel compounds as cannabinoid receptor ligands and uses thereof
02/18/2009EP2024348A2 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands
02/18/2009EP2024334A2 Substituted esters as cannabinoid-1 receptor modulators
02/18/2009EP2024329A2 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them
02/18/2009EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds
02/18/2009CN101370796A Thiazoles as 11 beta-HSD1 inhibitors
02/18/2009CN101370795A Method for producing thiazole compound
02/18/2009CN101370779A Cyclohexyl sulfonamide derivatives having H3 receptor activity
02/18/2009CN101370772A Diketooxime ester compound and use thereof
02/18/2009CN101367777A Novel production method of rubber vulcanization accelerant CZ
02/18/2009CN101367776A Novel production method of rubber vulcanization accelerant MBT
02/18/2009CN101367775A Rhodanine derivant, preparation method and uses thereof
02/17/2009US7491747 4-(Arylthio)- or (4-heteroarylthio)butyric acid derivatives that may be used in the treatment of dyslipidaemia, atherosclerosis and diabetes
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof
02/17/2009US7491725 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 337